Page last updated: 2024-12-09

Jasmone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

jasmone: RN refers to (Z)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1549018
CHEMBL ID2251602
CHEBI ID6084
SCHEMBL ID20385

Synonyms (65)

Synonym
3-methyl-2-[(z)-pent-2-enyl]cyclopent-2-en-1-one
2-cyclopenten-1-one, 3-methyl-2-(2-pentenyl)-, (z)-
einecs 207-668-4
brn 1907713
fema no. 3196
LMFA02020009
3-methyl-2-(pent-2z-enyl)cyclopent-2-enone
2-cyclopenten-1-one, 3-methyl-2-[(2z)-2-pentenyl]-
3-methyl-2-(2-cis-pentenyl)-2-cyclopenten-1-one
3-methyl-2-n-penten-2'-ylcyclopenten-2-one
(z)-jasmone
3-methyl-2-(2-pentenyl)-2-cyclopenten-1-one
2-cyclopenten-1-one, 3-methyl-2-(2-pentenyl)-, (z)- (8ci)
3-methyl-2-(cis-2-penten-1-yl)-2-cyclopenten-1-one
cmc_7381
3-methyl-2-(2-pentenyl)-2-cyclopenten-1-one, (z)-
cis-3-methyl-2-(2-pentenyl)-2-cyclopenten-1-one
3-methyl-2-(cis-2-pentenyl)-2-cyclopenten-1-one
3-methyl-2-pent-2-enylcyclopent-2-enone
jasmone (6ci)
2-cyclopenten-1-one, 3-methyl-2-(2z)-2-pentenyl- (9ci)
jasmone
488-10-8
cis-jasmone
C08490
cis-jasmone, stabilized
jasmone, 90%
cis-jasmon
J0003
dtxcid2027092
dtxsid4047092 ,
tox21_301825
NCGC00256139-01
cas-488-10-8
AKOS024318891
3-methyl-2-[(z)-pent-2-enyl]-cyclopent-2-en-1-one
unii-rc4w0g9yuk
4-07-00-00337 (beilstein handbook reference)
2-cyclopenten-1-one, 3-methyl-2-(2z)-2-penten-1-yl-
hsdb 8273
rc4w0g9yuk ,
S4960
(z)-3-methyl-2-(pent-2-en-1-yl)cyclopent-2-enone
SCHEMBL20385
CHEMBL2251602
chebi:6084 ,
methyl-2-(2-pentenyl)-2-cyclopenten-1-one, (z)-, 3-
jasmone [fhfi]
jasmone [mi]
3-methyl-2-[(2z)-2-pentenyl]-2-cyclopenten-1-one #
GS-3251
3-methyl-2-[(2z)-pent-2-en-1-yl]cyclopent-2-en-1-one
cis-3-methyl-2-pent-2-enyl-cyclopent-2-enone
jasmone, analytical standard
3-methyl-2-[(2z)-2-pentenyl]-2-cyclopenten-1-one
(z)-3-methyl-2-(2-pentenyl)-2-cyclopenten-1-one
BCP18948
HY-N7058
Q418077
cis-?jasmone
CCG-266315
AC7789
CS-W017899
2-cyclopenten-1-one, 3-methyl-2-(2z)-2- pentenyl-
EN300-7400412

Research Excerpts

Overview

Cis-Jasmone (CJ) is a plant-derived chemical that enhances direct and indirect plant defence against herbivorous insects. It acts as an attractant for pollinators and as a chemical cue for host localisation (or avoidance) for insects. Cis-jasmone is a highly appreciated fragrance and plant- derived signal molecule.

ExcerptReferenceRelevance
"cis-Jasmone (CJ) is a natural plant product that activates defence against herbivores in model and crop plants. "( Priming of Production in Maize of Volatile Organic Defence Compounds by the Natural Plant Activator cis-Jasmone.
Birkett, MA; Bruce, TJ; Caulfield, JC; Dewhirst, SY; Oluwafemi, S; Pickett, JA; Powers, S; Veyrat, N, 2013
)
1.16
"cis-jasmone (CJ) is a plant-derived chemical that enhances direct and indirect plant defence against herbivorous insects. "( The transcriptome of cis-jasmone-induced resistance in Arabidopsis thaliana and its role in indirect defence.
Bruce, TJ; Matthes, MC; Napier, JA; Pickett, JA; Ton, J; Verrier, PJ, 2010
)
1.22
"cis-Jasmone is a volatile organic compound emitted constitutively by flowers or leaves of several plant species where it acts as an attractant for pollinators and as a chemical cue for host localisation (or avoidance) for insects. "( Emerging roles in plant defense for cis-jasmone-induced cytochrome P450 CYP81D11.
Bruce, T; Chamberlain, K; Matthes, M; Napier, J; Pickett, J, 2011
)
1.19
"cis-Jasmone is a member of the fragrance structural group ketones cyclopentanones and cyclopentenones."( Fragrance material review on cis-jasmone.
Api, AM; Jones, L; Letizia, CS; Scognamiglio, J, 2012
)
1.14
"cis-Jasmone is a plant volatile known to have roles as an insect semiochemical and in inducing plant defence. "( cis-Jasmone treatment induces resistance in wheat plants against the grain aphid, Sitobion avenae (Fabricius) (Homoptera: Aphididae).
Bruce, TJ; Martin, JL; Pickett, JA; Pye, BJ; Smart, LE; Wadhams, LJ, 2003
)
1.44
"cis-Jasmone is known to be a plant activator in terms of production of defence-related volatile semiochemicals that repel aphids and increase the foraging activity of aphid parasitoids."( cis-Jasmone induces accumulation of defence compounds in wheat, Triticum aestivum.
Birkett, MA; Bromilow, R; Gordon-Weeks, R; Martin, JL; Moraes, MC; Pickett, JA; Pye, BJ; Smart, LE, 2008
)
1.38
"Cis-jasmone is a highly appreciated fragrance and plant-derived signal molecule that controls pollination, attracts parasitoids of attacking herbivores, and serves as an intra- and interspecific signal that controls gene expression. "( Iso-OPDA: an early precursor of cis-jasmone in plants?
Boland, W; Dabrowska, P, 2007
)
1.17

Effects

ExcerptReferenceRelevance
"Jasmone has no effect on the E1<-->E2 equilibrium constant for the ATPase or on Ca2+ binding."( Mechanism of stimulation of the calcium adenosinetriphosphatase by jasmone.
East, JM; Hughes, G; Lee, AG; Starling, AP, 1994
)
1.25

Dosage Studied

ExcerptRelevanceReference
" Our electrophysiological results show a dose-response relationship between the EAG amplitudes and the increasing concentrations of the olfactory compound."( Association between olfactory sensitivity and behavioral responses of Drosophila suzukii to naturally occurring volatile compounds.
Corda, G; Crnjar, R; Delogu, G; Dettori, MA; Fabbri, D; Solari, P; Sollai, G, 2020
)
0.56
" The dose-response analysis confirmed an allosteric type of AhR antagonism."( Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR).
Dvořák, Z; Krasulová, K; Marcalíková, A; Vrzal, R; Zemánková, L, 2023
)
2.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cyclic ketone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency68.58960.000221.22318,912.5098AID743042
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency38.57080.001022.650876.6163AID1224838
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.58960.003041.611522,387.1992AID1159552
pregnane X nuclear receptorHomo sapiens (human)Potency34.37620.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.94100.000229.305416,493.5996AID743069
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency38.57080.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1090712Thrips luring activity against male New Zealand Thrips obscuratus (flower thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
AID1090713Thrips luring activity against female New Zealand Thrips obscuratus (flower thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
AID1090711Thrips luring activity against female Thrips tabaci (onion thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (6.90)18.2507
2000's19 (32.76)29.6817
2010's26 (44.83)24.3611
2020's9 (15.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.76 (24.57)
Research Supply Index4.11 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index68.81 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other55 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]